Maryland Board of Pharmacy

03/09/2018

The National Boards of Pharmacy (NABP) is finalizing a new upgraded online system that will increase communication efficiency between NABP and the state boards of pharmacies, pharmacists, students, and technicians.
To install the new system NABP services will be unavailable from March 20, 2018 at 5 PM CT until approximately April 2, 2018 at 12 PM CT. During this time NABP testing applications, score reports, practice tests, licensure transfer applications, CPE Monitor, and publication ordering will not be available.
If you have questions or concerns please contact the Maryland Board of Pharmacy at 410-764-4755.

12/05/2017

FDA has a new recall.

The use of impacted alcohol prep pads could result in adverse events such as infections.

11/16/2017

Remember! All registered Maryland Licensed Pharmacists must register with PDMP. Feel free to check out this training video to get more insight on how PDMP is used.

PDMP Training video for Physicians and Prescribers in Maryland produced through Maryland Public Television for the Maryland Department of Health

10/06/2017

https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm576755.htm

Health care professionals should develop a treatment plan when buprenorphine or methadone is used in combination with benzodiazepines or other CNS depressants.

09/21/2017

DEA to Hold Next National Prescription Drug Take-Back Day on October 28

DEA has announced another opportunity for consumers to dispose of unneeded and expired prescription drugs during the 14th DEA National Prescription Drug Take-Back Day, which will be held Saturday, October 28, 2017. On this day, from 10 AM to 2 PM, thousands of temporary collection sites will be available across the country to accept unneeded prescription drugs, including CS, for safe and legal disposal. To date, DEA’s Take-Back Day initiative has collected a combined total of more than 900,000 pounds of unneeded medications, helping to prevent diversion, misuse, and abuse of the drugs.
NABP’s AWARXE® Prescription Drug Safety Program encourages consumer participation in DEA Take-Back Day events and provides information about the importance of safe drug disposal in helping to curb prescription drug abuse rates. Consumers who are unable to participate in the DEA Take-Back Day can find locations of permanent drug disposal sites using AWARXE’s Drug Disposal Locator Tool.

Drug disposal location information will be available October 1, 2017 at the following website:
https://www.deadiversion.usdoj.gov/drug_disposal/takeback/

Permanent US drug disposal sites for consumers. Temporary “take-back day” and commercial disposal sites not listed. Want to add a disposal site?

07/19/2017

Have unused prescriptions? Drop them off at one of these locations: https://goo.gl/BDhgES

06/13/2017

PHARMACEUTICAL RECALL NOTICE!

Bristol-Myers Squibb Company (NYSE: BMY) is voluntarily recalling one lot ( ) of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the U.S. to wholesalers and retail pharmacies in February 2017. Bristol-Myers Squibb is taking this precautionary measure based on a customer complaint that a bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets.

Visit our website at health.maryland.gov/pharmacy to stay up to date on pharmaceutical recalls.

https://www.fda.gov/Safety/Recalls/ucm563002.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

Bristol-Myers Squibb Company (NYSE: BMY) is voluntarily recalling one lot ( ) of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the U.S. to wholesalers and retail pharmacies in February 2017. Bristol-Myers Squibb is taking this precautionary measure based on...

06/07/2017

The new State Advisory Council on Health and Wellness will take effect October 1, 2017. The Council's duties include providing guidance on Statewide chronic disease prevention and control and the promotion of evidence-based programs for healthy lifestyles.

The Council has 18 seats for members from the general public. Licensed healthcare providers, representatives of health insurers, representatives of the business sector as well as individuals with an interest in chronic disease, health and wellness, or physical fitness are encouraged to apply by clicking the link below. Applications will be accepted from June 7, 2017 through August 1, 2017. Appointments will be announced October 1, 2017.

http://forms.dhmh.maryland.gov/

This is a two part application process, please complete BOTH the Biographical Information form and the Ethics Exemption Disclosure form. Failure to complete either one of these forms will prevent us from accepting your application for Appointment consideration. Please state here, the board or commis...

05/19/2017

Alert from the Opioid Operational Command Center regarding counterfeit oxycodone tablets containing fentanyl.

"We've received this information from Maryland State Police and are sharing for your situational awareness.

Bogus oxycodone tablets containing fentanyl (blue or white in color) have been found in Queen Anne’s, Cecil, and Anne Arundel counties.

Should any suspicious tablets be found, we ask that you contact your local law enforcement agency.

We thank you for your time and attention to this matter. Your engagement and partnership in this process is greatly appreciated as we all continue working together to drive a safer future for all Marylanders"

05/08/2017

Maryland Opioid Operational Command Center Alert: Carfentanil Overdose Deaths

http://dhmh.maryland.gov/pharmacy/docs/News%20Updates/Carfentanil%20letter%205.5.17.pdf

05/04/2017

Don't forget! All Maryland Pharmacists are required to be registered with PDMP by July 1, 2017. Click the link to register.

For our PDMP FAQs please go herehttp://dhmh.maryland.gov/pharmacy/docs/News%20Updates/PDMP%20FAQ%20(2).pdf

Clinical users register for access to the Maryland Prescription Drug Monitoring Program (PDMP) data through CRISP exclusively. Registration is simple, free of charge, and takes only a few minutes.

04/25/2017